Oscar Health, Inc. $OSCR Shares Sold by Dragoneer Investment Group LLC

Dragoneer Investment Group LLC cut its stake in Oscar Health, Inc. (NYSE:OSCR) by 51.2% during the 4th quarter, HoldingsChannel reports. The fund owned 657,435 shares of the company’s stock after selling 688,719 shares during the period. Oscar Health comprises 0.2% of Dragoneer Investment Group LLC’s portfolio, making the stock its 24th largest position. Dragoneer Investment Group LLC’s holdings in Oscar Health were worth $9,447,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. BIT Capital GmbH raised its holdings in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the period. American Century Companies Inc. raised its holdings in shares of Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock worth $100,298,000 after purchasing an additional 2,495,691 shares during the period. Farallon Capital Management LLC raised its holdings in shares of Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the period. Morgan Stanley raised its holdings in shares of Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after purchasing an additional 2,043,758 shares during the period. Finally, Thrive Capital Management LLC raised its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

OSCR has been the topic of a number of research reports. Weiss Ratings raised shares of Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 9th. Zacks Research cut shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 5th. Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the stock an “equal weight” rating in a report on Thursday, June 4th. Barclays raised shares of Oscar Health from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $30.00 to $35.00 in a report on Wednesday, June 10th. Finally, Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and increased their target price for the stock from $10.00 to $16.00 in a report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.78.

Oscar Health Stock Down 2.3%

OSCR stock opened at $28.46 on Wednesday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $29.81. The firm’s 50-day simple moving average is $20.72 and its 200 day simple moving average is $16.71. The stock has a market cap of $8.58 billion, a PE ratio of -48.24, a price-to-earnings-growth ratio of 2.04 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. Oscar Health’s revenue was up 52.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.92 EPS. As a group, sell-side analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current year.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 100,000 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $23.16, for a total value of $2,316,000.00. Following the completion of the transaction, the chief financial officer owned 1,216,660 shares in the company, valued at $28,177,845.60. This represents a 7.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mario Schlosser sold 34,120 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80. Following the completion of the transaction, the director owned 480,866 shares of the company’s stock, valued at $10,550,200.04. This represents a 6.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 189,660 shares of company stock worth $4,283,140 over the last ninety days. Insiders own 25.11% of the company’s stock.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.